http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11506453-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 1996-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H11506453-A |
| titleOfInvention | Water-soluble camptothecin analog |
| abstract | (57) SUMMARY OF THE INVENTION The present invention is especially useful as an antitumor agent of the formula I: A pharmaceutical composition thereof; and a method of treating cancer in an animal, including a human, in need thereof, wherein the administration of an effective amount of a compound of formula I inhibits the growth of tumor cells in said animal. Providing a method comprising: |
| priorityDate | 1995-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.